AMLX Amylyx Pharmaceuticals, Inc.
$31.62▼ -1.46%
Healthcare
Other
After hours
$31.72▲ +0.32%
Sep 11, 7:47 PM ET
Volume 1.71M
Avg Volume (10D) 1.62M
Key Metrics & Fundamentals
Market Cap
$3.52B
P/E Ratio
–
Div Yield
–%
52W Range
10.83 - 41.14
% vs 50 MA
24.60%
% vs 200 MA
83.45%
RSI-14
52.9
MACD Histogram
-0.9800
Beta (1Y vs SPY)
0.78
Free Cash Flow
-$31.45M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$45.65M
COGS
–
Operating Exp
$45.69M
Operating Income
-$45.69M
EBIT
-$45.69M
Pretax Income
-$43.42M
Net Income
-$43.42M
EPS (Diluted)
-0.39
Price & Volume History
Loading chart…
Recent News
Tortugas Neuroscience Announces Appointment of Jim Frates to Board of Directors
Business Wire · Sep 9, 2026 12:00 PM
Amylyx Pharmaceuticals to Present at the 24th Annual Morgan Stanley Global Healthcare Conference
Business Wire · Sep 8, 2026 1:00 PM
Is GLP-1 Stock Amylyx Still a Buy After Skyrocketing 247%?
Motley Fool · Sep 1, 2026 1:50 PM
Should Eli Lilly Investors Be Worried About a Threat From Amylyx?
Motley Fool · Aug 30, 2026 4:35 PM
Oracle Stock And 2 High Growth Picks Backed By Rising Credit Demand
Simply Wall St. · Aug 27, 2026 4:24 PM
Oracle Stock And 2 Growth Picks With Strong Earnings Potential
Simply Wall St. · Aug 26, 2026 4:38 AM
Why Amylyx Pharmaceuticals Blasted Nearly 79% Higher This Week
Motley Fool · Aug 21, 2026 10:00 PM
Amylyx (AMLX) Faces a Binary Phase 3 Test. Can Avexitide Rebuild the Company?
Insider Monkey · Aug 21, 2026 9:58 PM
Why Did IOVA, AMLX And COP Stocks Surge To 52-Week Highs Today?
Stocktwits · Aug 21, 2026 3:57 AM
Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock
Business Wire · Aug 20, 2026 3:06 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See AMLX's money flow as a full page
Social Sentiment
No Reddit posts found for AMLX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.